167 related articles for article (PubMed ID: 18837064)
1. Brain transport of neurotoxin-I with PLA nanoparticles through intranasal administration in rats: a microdialysis study.
Cheng Q; Feng J; Chen J; Zhu X; Li F
Biopharm Drug Dispos; 2008 Nov; 29(8):431-9. PubMed ID: 18837064
[TBL] [Abstract][Full Text] [Related]
2. [Brain delivery of neurotoxin-I-loaded nanoparticles through intranasal administration].
Cheng QY; Feng J; Li FZ
Yao Xue Xue Bao; 2008 Apr; 43(4):431-4. PubMed ID: 18664209
[TBL] [Abstract][Full Text] [Related]
3. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats.
Zhang X; Liu L; Chai G; Zhang X; Li F
Drug Dev Ind Pharm; 2013 Nov; 39(11):1618-24. PubMed ID: 24087853
[TBL] [Abstract][Full Text] [Related]
4. Delivery of 125I-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats.
Li F; Feng J; Cheng Q; Zhu W; Jin Y
Int J Pharm; 2007 Jan; 328(2):161-7. PubMed ID: 17049426
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
[TBL] [Abstract][Full Text] [Related]
6. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
Wang X; Chi N; Tang X
Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
Parikh T; Bommana MM; Squillante E
Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
[TBL] [Abstract][Full Text] [Related]
8. [Effect of borneol/mentholum eutectic mixture on nasal-brain delivery of neurotoxin loaded nanoparticles].
Chai G; Pan Y; Li F
Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(6):698-701. PubMed ID: 19624007
[TBL] [Abstract][Full Text] [Related]
9. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.
Gao X; Wu B; Zhang Q; Chen J; Zhu J; Zhang W; Rong Z; Chen H; Jiang X
J Control Release; 2007 Aug; 121(3):156-67. PubMed ID: 17628165
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of phospholipid complex loaded nanoparticles enhancing the oral bioavailability.
Peng Q; Zhang ZR; Sun X; Zuo J; Zhao D; Gong T
Mol Pharm; 2010 Apr; 7(2):565-75. PubMed ID: 20166756
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-mediated delivery of neurotoxin-II to the brain with intranasal administration: an effective strategy to improve antinociceptive activity of neurotoxin.
Ruan Y; Yao L; Zhang B; Zhang S; Guo J
Drug Dev Ind Pharm; 2012 Jan; 38(1):123-8. PubMed ID: 21721852
[TBL] [Abstract][Full Text] [Related]
12. Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses.
Al-Ghananeem AM; Saeed H; Florence R; Yokel RA; Malkawi AH
J Drug Target; 2010 Jun; 18(5):381-8. PubMed ID: 20001275
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits.
Kaur P; Kim K
Int J Pharm; 2008 Nov; 364(1):27-35. PubMed ID: 18760341
[TBL] [Abstract][Full Text] [Related]
14. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive properties of nasal delivery of neurotoxin-loaded nanoparticles coated with polysorbate-80.
Ruan Y; Yao L; Zhang B; Zhang S; Guo J
Peptides; 2011 Jul; 32(7):1526-9. PubMed ID: 21600257
[TBL] [Abstract][Full Text] [Related]
16. [Study on chitosan-modified tripterygium glycoside nanoparticles and its renal targeting property].
Chen XK; Wei YH; Yao JN; Zhao YM; Shang XG; Li FZ
Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(4):548-52. PubMed ID: 23713281
[TBL] [Abstract][Full Text] [Related]
17. Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery.
Jain SK; Gupta Y; Jain A; Saxena AR; Khare P; Jain A
Nanomedicine; 2008 Mar; 4(1):41-8. PubMed ID: 18207463
[TBL] [Abstract][Full Text] [Related]
18. PLA-PEG particles as nasal protein carriers: the influence of the particle size.
Vila A; Sánchez A; Evora C; Soriano I; McCallion O; Alonso MJ
Int J Pharm; 2005 Mar; 292(1-2):43-52. PubMed ID: 15725552
[TBL] [Abstract][Full Text] [Related]
19. UEA I-bearing nanoparticles for brain delivery following intranasal administration.
Gao X; Chen J; Tao W; Zhu J; Zhang Q; Chen H; Jiang X
Int J Pharm; 2007 Aug; 340(1-2):207-15. PubMed ID: 17499948
[TBL] [Abstract][Full Text] [Related]
20. Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier.
Jain AK; Khar RK; Ahmed FJ; Diwan PV
Eur J Pharm Biopharm; 2008 Jun; 69(2):426-35. PubMed ID: 18295464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
